UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

Journal of clinical oncology, 2017-05, Vol.35 (15), p.1641-1649

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Journal of clinical oncology, 2012-07, Vol.30 (21), p.2601-2608

2012

Link zum Volltext

Verfügbarkeit prüfen

FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer

Journal of clinical oncology, 2012-06, Vol.30 (16), p.1919-1925

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study

Journal of clinical oncology, 2011-01, Vol.29 (3), p.264-271

2011

Link zum Volltext

Verfügbarkeit prüfen

First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study

Journal of clinical oncology, 2012-03, Vol.30 (9), p.921-929

2012

Link zum Volltext

Verfügbarkeit prüfen

Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations

Journal of clinical oncology, 2010-04, Vol.28 (12), p.2114-2122

2010

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Prognosis of Synchronous and Metachronous Bilateral Breast Cancer

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4210-4216

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

Journal of clinical oncology, 2023-09, Vol.41 (27), p.JCO2300062-4380

2023

Link zum Volltext

Verfügbarkeit prüfen

Is Estradiol Monitoring Necessary in Women Receiving Ovarian Suppression for Breast Cancer?

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1573-1579

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum thymidine kinase 1 and its kinetics in HER2-positive breast cancer: Results from the Swedish phase II PREDIX HER2 trial

JOURNAL OF CLINICAL ONCOLOGY, 2022, Vol.40 (16_suppl), p.e12598-e12598

2022

Link zum Volltext

Verfügbarkeit prüfen

PREDIX II HER2: Improving pre-operative systemic therapy for human epidermal growth factor receptor 2 (HER2) amplified breast cancer (BC)

JOURNAL OF CLINICAL ONCOLOGY, 2020, Vol.38 (15_suppl), p.TPS605-TPS605

2020

Link zum Volltext

Verfügbarkeit prüfen

Sisyphean Efforts: Establishing the Correct Risk-Benefit Balance for Adjuvant Therapies

Journal of clinical oncology, 2016-03, Vol.34 (9), p.895-897

2016

Link zum Volltext

Verfügbarkeit prüfen

Reply to A.Y. Lin

Journal of clinical oncology, 2017-01, Vol.35 (1), p.121-122

2017

Link zum Volltext

Verfügbarkeit prüfen

Patients’ perspective on the quality of prostate cancer follow-up care

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.175-175

2021

Link zum Volltext

Verfügbarkeit prüfen

Durable remissions with Ipilimumab in pretreated metastatic malignant melanoma (MMM) patients (pts): Results of a South African Expanded Access Program (EAP)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20112-e20112

2015

Link zum Volltext

Verfügbarkeit prüfen

The field of radiation therapy may effect health-related quality of life in patients with operable breast cancer

Journal of clinical oncology, 2004-05, Vol.22 (9), p.1765; author reply 1765-1765

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)

Sprache

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(13)
Life Sciences & Biomedicine
(12)
Oncology
(12)
Science & Technology
(12)
Humans
(11)
Female
(10)
Adult
(6)
Middle Aged
(6)
Aged
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Biological And Medical Sciences
(4)
Breast Neoplasms - Drug Therapy
(4)
Gynecology. Andrology. Obstetrics
(4)
Mammary Gland Diseases
(4)
Medical Sciences
(4)
Tumors
(4)
Cancer And Oncology
(3)
Cancer Och Onkologi
(3)
Cancer Research
(3)
Receptor, Erbb-2 - Metabolism
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(17)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(17)
Single Journals
(17)
IngentaConnect Journals
(16)
Ingenta
(16)
MEDLINE
(11)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
(1)

Menü

Weitere Dienste

Einstellungen

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease

First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study

Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations

Incidence and Prognosis of Synchronous and Metachronous Bilateral Breast Cancer

Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

Is Estradiol Monitoring Necessary in Women Receiving Ovarian Suppression for Breast Cancer?

Serum thymidine kinase 1 and its kinetics in HER2-positive breast cancer: Results from the Swedish phase II PREDIX HER2 trial

PREDIX II HER2: Improving pre-operative systemic therapy for human epidermal growth factor receptor 2 (HER2) amplified breast cancer (BC)

Sisyphean Efforts: Establishing the Correct Risk-Benefit Balance for Adjuvant Therapies

Reply to A.Y. Lin

Patients’ perspective on the quality of prostate cancer follow-up care

Durable remissions with Ipilimumab in pretreated metastatic malignant melanoma (MMM) patients (pts): Results of a South African Expanded Access Program (EAP)

The field of radiation therapy may effect health-related quality of life in patients with operable breast cancer

Aktive Filter

Suchergebnisse filtern